How Can We Justify AI’s Cost?

The industry’s struggle to control rampant costs is forcing executives to dig more deeply into their technology spending habits – especially where and how much they want to invest in AI. And that’s forcing them to confront different definitions of ROI.

Read More »

Accelerating Cancer Innovation

From our inception over 20 years ago, we have accelerated cancer drug innovation by leveraging India’s robust scientific ecosystem and forming beneficial partnerships with industry leaders. These strategic cornerstones have enabled us to build a faster, more cost-effective drug discovery and development model.

Read More »